Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Allergen immunotherapy (5)
  • AllergoOncology (2)
  • Allergy diagnosis (28)
  • Allied health and primary care (2)
  • Anaphylaxis (13)
  • Artificial Intelligence (2)
  • Asthma (16)
  • Basic immunology (3)
  • x Biologicals (5)
  • Biomarkers (3)
  • COVID19 (2)
  • Dermatology (20)
  • Drug allergy (13)
  • ENT (4)
  • Environmental allergy and climate change (1)
  • Eosinophilic esophagitis (1)
  • Epidemiology (4)
  • Food allergy (18)
  • Genomics and proteomics (1)
  • Immune deficiencies and autoimmunity (7)
  • Immunomodulation and nutrition (1)
  • Infections (5)
  • Insect venom hypersensitivities (4)
  • Mastocytosis and mast cells (1)
  • Microbiome (1)
  • Occupational allergy (2)
  • One Health (1)
  • Pediatrics (13)
  • Prevention (2)
Poster available until
Poster categories
  • x e-Thematic Poster Session (5)
  • Thematic Poster Session (70)
keywords
Session Reference
5 results
Thumbnail

000140 - Effectiveness of Tezepelumab in uncontrolled severe asthma. ADVANCAT (Advancing severe asthma care with Tezepelumab in Catalonia)

Thumbnail

000486 - Objective and Subjective Sleep Assessments in Patients With Atopic Dermatitis Treated With Dupilumab: Results From DUPISTAD, a Phase 4 Randomized Placebo-Controlled Study

Thumbnail

100006 - A real-world study of tezepelumab in severe asthmatics of a French cohort

Thumbnail

100455 - Ocrelizumab-associated secondary hypogammaglobulinemia and sever pneumonia: Case Report

Thumbnail

D3.97 - Postoperative Anti-IgE Therapy for Chronic Rhinosinusitis with Nasal Polyps and Asthma: Efficacy and Prognostic Factors

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM